June 14, 2011 — Merge Healthcare announced today that it has signed a definitive agreement to acquire Ophthalmic Imaging Systems (OIS), which provides digital imaging and informatics solutions for ophthalmology and other medical specialties.

June 13, 2011 – Today, GE Healthcare Medical Diagnostics announced results of a study evaluating the cardiopulmonary safety of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a Food and Drug Administration (FDA)-approved diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.

The U.S. Food and Drug Administration (FDA) gave 510(k) clearance to Konica Minolta Medical Imaging’s Regius Sigma tabletop computed radiography (CR) reader. The reader is offered as an affordable solution for lower volume clinics and practices, including orthopedic, chiropractic and veterinary.

June 14, 2011 – Positron, a molecular imaging company specializing in the field of nuclear cardiology, is relocating its corporate headquarters, research and development and product manufacturing facilities to Noblesville, Ind. Positron also plans to develop a high-energy 70 MeV cyclotron project and radiopharmaceutical manufacturing facility, also to be located in Noblesville.

June 14, 2011 – Definitive proof of an adverse effect of chronic marijuana use revealed at SNM’s 58th annual meeting could lead to potential drug treatments and aid other research involved in cannabinoid receptors, a neurotransmission system receiving a lot of attention. Scientists used molecular imaging to visualize changes in the brains of heavy marijuana smokers versus non-smokers and found that abuse of the drug led to a decreased number of cannabinoid CB1 receptors, which are involved not only in pleasure, appetite and pain tolerance, but also in a host of other psychological and physiological functions of the body.

The American Society of Echocardiography (ASE) and lifeIMAGE today announced a partnership that will give ASE members the ability to exchange medical images and data with anyone, anywhere.

June 14, 2011 – Accuray announced that it has completed its previously announced acquisition of TomoTherapy. The combined company is focused on developing, manufacturing and selling personalized treatment solutions that revolve around the patient.

June 14, 2011 —A study revealed at SNM’s 58th annual meeting is comparing the breast-tumor detection capabilities of two very different imaging technologies — breast-specific gamma imaging (BSGI), which provides functional images of breast physiology, and ultrasound — for women with complex breast imaging cases that require further evaluation. Many women who have dense breast tissue (radiodense breasts) are difficult to image using mammography, currently the gold standard of breast imaging. For women whose mammograms are not clear enough to determine whether cancer is present, support methods such as BSGI and ultrasound are used to answer any remaining diagnostic questions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now